BRIEF published on 06/27/2024 at 18:35, 4 months 23 days ago Arcure will host its biannual webinar on July 17, 2024 Investors Webinar 2024 Turnover Arcure
BRIEF published on 06/17/2024 at 18:35, 5 months 3 days ago Arcure accelerates its globalization and opens an office in Barcelona Artificial Intelligence 2023 Barcelona Internationalization Arcure
BRIEF published on 06/06/2024 at 18:05, 5 months 14 days ago Arcure announces the publication of its first Letter to Shareholders Investors Industrial Security Financial Publication Arcure Letter To Shareholders
BRIEF published on 05/22/2024 at 18:05, 5 months 29 days ago Information on Arcure's voting rights and shares as of April 30, 2024 Voting Rights Actions Artificial Intelligence Euronext Growth Arcure
BRIEF published on 05/14/2024 at 08:05, 6 months 7 days ago Arcure launches its new AI platform for industrial vehicles Artificial Intelligence Technological Innovation Industrial Security Arcure Embedded Software
BRIEF published on 04/30/2024 at 08:05, 6 months 21 days ago Arcure announces the publication of its 2023 financial report Artificial Intelligence Financial Report Industry Industrial Security Arcure
Published on 11/21/2024 at 13:30, 14 minutes ago AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 14 minutes ago Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 44 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 44 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 44 minutes ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 12:35, 1 hour 9 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 29 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 6 hours 46 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 24 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 19 hours 59 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 19 hours 59 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 5 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
